Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1 participants
INTERVENTIONAL
2022-10-24
2023-07-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapeutic Thoracentesis for Patients With Congestive Heart Failure and Large Pleural Effusion
NCT00629538
Thoracentesis to Alleviate Cardiac Pleural Effusion
NCT05017753
LYmphangiogenesis FacTors in Heart Failure States
NCT03141567
Congestive Heart Failure Surgical Treatmment With Autologous Stem Cell Therapy
NCT00480961
Assessment of Functional Capacity and Inflammatory Markers in Women With Heart Failure With Preserved Ejection Fraction
NCT02649400
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TD Drainage
Short term TD drainage
TD Drainage
Image-guided percutaneous cannulation of the TD and drainage with an endovascular catheter (microcatheter)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TD Drainage
Image-guided percutaneous cannulation of the TD and drainage with an endovascular catheter (microcatheter)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects with informed consent to participate
* NYHA III- IV patients
* Patients with heart failure volume overload
* Planned for elective right heart catheterization
Exclusion Criteria
* Local infection or ongoing systemic infection(s)
* Thrombotic coagulation disorder
* On continuous blood thinners that cannot be discontinued or held
* Allergy or contraindications to the use of iodine-based contrast agents
* Subjects deemed to be high risk for performing a cardiac catheterization by study investigator
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marat Fudim, MD
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Marat Fudim
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00107814
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.